Comparative Pharmacology
Head-to-head clinical analysis: COLOVAGE versus DUPHALAC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: COLOVAGE versus DUPHALAC.
COLOVAGE vs DUPHALAC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
COLOVAGE is a bowel cleansing preparation containing polyethylene glycol 3350 and electrolytes. It acts as an osmotic laxative, causing fluid retention in the colon to stimulate bowel evacuation.
Duphalac (lactulose) is a synthetic disaccharide that is not absorbed in the gastrointestinal tract. It is metabolized by colonic bacteria to short-chain fatty acids (e.g., acetic, lactic, formic acids), which lower colonic pH. This acidic environment favors the conversion of ammonia (NH3) to ammonium (NH4+), which is trapped in the colon and excreted in feces, thereby reducing systemic ammonia absorption. Additionally, the osmotic effect of lactulose and its metabolites draws water into the colon, producing a laxative effect.
4 liters of PEG-3350 electrolyte solution orally as a single dose for colon cleansing prior to colonoscopy; alternatively, 2 liters with ascorbic acid regimen.
Oral: 15-30 mL once daily, may increase to 30-45 mL twice daily if needed. Rectal (enema): 150-300 mL as a single dose.
None Documented
None Documented
Not applicable (non-absorbed, gut lavage); systemic absorption minimal
Not applicable; systemic exposure is negligible. Orally administered lactulose acts locally in the colon.
Primarily fecal as unabsorbed drug; negligible renal excretion (<5%)
Lactulose is not absorbed from the gastrointestinal tract; it is excreted unchanged in feces (>99%).
Category C
Category C
Osmotic Laxative
Osmotic Laxative